Australia Generic Drug Market (2025-2031) | Trends, Analysis, Outlook, Size & Revenue, Segmentation, Growth, Industry, Competitive Landscape, Companies, Share, Forecast, Value

Market Forecast By Type (Simple Generics, Super Generics), By Brand (Pure Generic, Branded Generic), By Indication (Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory, Others), By Route of Administration (Oral, Topical, Parenteral, Others), By End-Users (Hospitals, Homecare, Specialty Clinics, Others) And Competitive Landscape
Product Code: ETC6181614 Publication Date: Sep 2024 Updated Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Generic Drug Market Overview

The generic drug market in Australia plays a crucial role in ensuring affordable access to essential medicines. Driven by the need to reduce healthcare costs, the market has experienced consistent growth. Government policies such as the Pharmaceutical Benefits Scheme (PBS) have promoted the use of generics by offering reimbursement incentives. Local manufacturers and international players both compete in this space, with a strong focus on producing bioequivalent alternatives to branded drugs. Increased prevalence of chronic diseases and rising awareness among consumers about cost-effective alternatives further support market expansion.

Trends of the market

The generic drug market in Australia is witnessing steady growth, driven by an increasing focus on cost-effective alternatives to branded drugs. The government’s Pharmaceutical Benefits Scheme (PBS) continues to play a pivotal role in encouraging the use of generics through incentives and regulatory support. The expiration of patents on blockbuster drugs is opening new opportunities for generic manufacturers. Furthermore, the rising incidence of chronic diseases and the aging population are increasing demand for affordable medication, positioning generics as an essential component of healthcare delivery.

Challenges of the market

The Australian generic drug market faces challenges in pricing pressures, as government policies like the Pharmaceutical Benefits Scheme (PBS) drive prices downward. Additionally, competition from biosimilars and complex regulatory approval processes for new generics make it harder for manufacturers to maintain profitability and market share.

Investment opportunities in the Market

Australia`s generic drug market provides steady investment opportunities due to rising healthcare costs and the government`s push for affordable medicines. Investment prospects exist in manufacturing, distribution, and retail of off-patent drugs. Companies that can comply with Australia’s stringent regulatory framework and maintain cost-efficiency stand to benefit. There`s also potential for expanding generic drug portfolios to treat chronic conditions such as diabetes, cardiovascular diseases, and mental health disorders, which are prevalent in the country.

Government Policy of the market

The Pharmaceutical Benefits Scheme (PBS) and the Therapeutic Goods Administration (TGA) guidelines dominate the regulatory environment for generic drugs in Australia. Government initiatives aim to encourage generic drug uptake to reduce healthcare costs, while strict quality and bioequivalence requirements ensure public safety.

Key Highlights of the Report:

  • Australia Generic Drug Market Outlook
  • Market Size of Australia Generic Drug Market, 2024
  • Forecast of Australia Generic Drug Market, 2031
  • Historical Data and Forecast of Australia Generic Drug Revenues & Volume for the Period 2021- 2031
  • Australia Generic Drug Market Trend Evolution
  • Australia Generic Drug Market Drivers and Challenges
  • Australia Generic Drug Price Trends
  • Australia Generic Drug Porter's Five Forces
  • Australia Generic Drug Industry Life Cycle
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Simple Generics for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Super Generics for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Brand for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Pure Generic for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Branded Generic for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Central Nervous System (CNS) for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Cardiovascular for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Dermatology for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Oncology for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Respiratory for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Topical for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of Australia Generic Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • Australia Generic Drug Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Brand
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Australia Generic Drug Top Companies Market Share
  • Australia Generic Drug Competitive Benchmarking By Technical and Operational Parameters
  • Australia Generic Drug Company Profiles
  • Australia Generic Drug Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Generic Drug Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Generic Drug Market Revenues & Volume, 2021 & 2031F

3.3 Australia Generic Drug Market - Industry Life Cycle

3.4 Australia Generic Drug Market - Porter's Five Forces

3.5 Australia Generic Drug Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Australia Generic Drug Market Revenues & Volume Share, By Brand, 2021 & 2031F

3.7 Australia Generic Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 Australia Generic Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Australia Generic Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 Australia Generic Drug Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Australia Generic Drug Market Trends

6 Australia Generic Drug Market, By Types

6.1 Australia Generic Drug Market, By Type

6.1.1 Overview and Analysis

6.1.2 Australia Generic Drug Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Australia Generic Drug Market Revenues & Volume, By Simple Generics, 2021- 2031F

6.1.4 Australia Generic Drug Market Revenues & Volume, By Super Generics, 2021- 2031F

6.2 Australia Generic Drug Market, By Brand

6.2.1 Overview and Analysis

6.2.2 Australia Generic Drug Market Revenues & Volume, By Pure Generic, 2021- 2031F

6.2.3 Australia Generic Drug Market Revenues & Volume, By Branded Generic, 2021- 2031F

6.3 Australia Generic Drug Market, By Indication

6.3.1 Overview and Analysis

6.3.2 Australia Generic Drug Market Revenues & Volume, By Central Nervous System (CNS), 2021- 2031F

6.3.3 Australia Generic Drug Market Revenues & Volume, By Cardiovascular, 2021- 2031F

6.3.4 Australia Generic Drug Market Revenues & Volume, By Dermatology, 2021- 2031F

6.3.5 Australia Generic Drug Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.6 Australia Generic Drug Market Revenues & Volume, By Respiratory, 2021- 2031F

6.3.7 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F

6.4 Australia Generic Drug Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Australia Generic Drug Market Revenues & Volume, By Oral, 2021- 2031F

6.4.3 Australia Generic Drug Market Revenues & Volume, By Topical, 2021- 2031F

6.4.4 Australia Generic Drug Market Revenues & Volume, By Parenteral, 2021- 2031F

6.4.5 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F

6.5 Australia Generic Drug Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Australia Generic Drug Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Australia Generic Drug Market Revenues & Volume, By Homecare, 2021- 2031F

6.5.4 Australia Generic Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.5 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F

7 Australia Generic Drug Market Import-Export Trade Statistics

7.1 Australia Generic Drug Market Export to Major Countries

7.2 Australia Generic Drug Market Imports from Major Countries

8 Australia Generic Drug Market Key Performance Indicators

9 Australia Generic Drug Market - Opportunity Assessment

9.1 Australia Generic Drug Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Australia Generic Drug Market Opportunity Assessment, By Brand, 2021 & 2031F

9.3 Australia Generic Drug Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 Australia Generic Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Australia Generic Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 Australia Generic Drug Market - Competitive Landscape

10.1 Australia Generic Drug Market Revenue Share, By Companies, 2024

10.2 Australia Generic Drug Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All